tirzepatide zepbound cost for Vials Cut to Battle Cheaper Copycats Eli Lilly's Popular Weight Loss
Description
On Friday, the states Medicaid administrator, MassHealth, ended coverage of GLP-1s and other medications when theyre prescribed solely for weight loss, saying the expense has become overwhelming
Eli Lilly is simultaneously running Phase 3 trials for oral tirzepatide
These physical health issues stem from a combination of lifestyle factors and genetic predispositions
Both are available in standard and microdosing formats
Zepbound has shown average weight loss of more than 20% in late-stage studies
It is also sold as a dietary supplement and is often included in products that claim to promote hair growth (National Institutes of Health 2022)
